Abstract:Nanoscale alteration of the molecular association between GABAB receptor and the CaV2.1 channel in actives zones the hippocampus of APP/PS1 mice. In wild‐type animals, the GABAB receptor and the CaV2.1 channel showed a high degree of co‐clustering in nanodomains (40 nm) of presynaptic active zones of axon terminals (at) establishing synapses with spines (s) of CA1 pyramidal cells. In APP/PS1 animals, the co‐clustering is lost, and molecules are detected at distances larger than 70 nm. Voltage‐gated CaV2.1 (P/Q‐type) Ca2+ channels play a crucial role in regulating neurotransmitter release, thus contributing to synaptic plasticity and to processes such as learning and memory. Despite their recognized importance in neural function, there is limited information on their potential involvement in neurodegenerative conditions such as Alzheimer's disease (AD). Here, we aimed to explore the impact of AD pathology on the density and nanoscale compartmentalization of CaV2.1 channels in the hippocampus in association with GABAB receptors. Histoblotting experiments showed that the density of CaV2.1 channel was significantly reduced in the hippocampus of APP/PS1 mice in a laminar‐dependent manner. CaV2.1 channel was enriched in the active zone of the axon terminals and was present at a very low density over the surface of dendritic tree of the CA1 pyramidal cells, as shown by quantitative SDS‐digested freeze‐fracture replica labelling (SDS‐FRL). In APP/PS1 mice, the density of CaV2.1 channel in the active zone was significantly reduced in the strata radiatum and lacunosum‐moleculare, while it remained unaltered in the stratum oriens. The decline in Cav2.1 channel density was found to be associated with a corresponding impairment in the GABAergic synaptic function, as evidenced by electrophysiological experiments carried out in the hippocampus of APP/PS1 mice. Remarkably, double SDS‐FRL showed a co‐clustering of CaV2.1 channel and GABAB1 receptor in nanodomains (~40–50 nm) in wild type mice, while in APP/PS1 mice this nanoarchitecture was absent. Together, these findings suggest that the AD pathology‐induced reduction in CaV2.1 channel density and CaV2.1‐GABAB1 de‐clustering may play a role in the synaptic transmission alterations shown in the AD hippocampus. Therefore, uncovering these layer‐dependent changes in P/Q calcium currents associated with AD pathology can benefit the development of future strategies for AD management.

Nanoscale organization is changed in native, surface AMPARs by mouse brain region and tauopathy

Nanoscale Reorganisation of Synaptic Proteins in Alzheimer's Disease

Different modes of synaptic and extrasynaptic NMDA receptor alteration in the hippocampus of P301S tau transgenic mice

Super-Resolution Imaging Uncovers Nanoscale Tau Aggregate Hyperphosphorylation Patterns in Human Alzheimer’s Disease Brain Tissue

Nanoscale imaging of pT217‐tau in aged rhesus macaque entorhinal and dorsolateral prefrontal cortex: Evidence of interneuronal trafficking and early‐stage neurodegeneration

Age-Dependent Shift of AMPA Receptors From Synapses to Intracellular Compartments in Alzheimer's Disease: Immunocytochemical Analysis of the CA1 Hippocampal Region in APP/PS1 Transgenic Mouse Model

Microglial lipid droplet accumulation in tauopathy brain is regulated by neuronal AMPK

Celebrating the Birthday of AMPA Receptor Nanodomains: Illuminating the Nanoscale Organization of Excitatory Synapses with 10 Nanocandles

Nanoarchitecture of CaV2.1 channels and GABAB receptors in the mouse hippocampus: Impact of APP/PS1 pathology

Selective disruption of synaptic NMDA receptors of the hippocampal trisynaptic circuit in Aβ pathology

Age-dependent impairment of cognitive and synaptic function in the htau mouse model of tau pathology

Correlative Assembly of Subsynaptic Nanoscale Organizations During Development

Single‐Molecule Characterization and Super‐Resolution Imaging of Alzheimer's Disease‐Relevant Tau Aggregates in Human Samples

Tau forms synaptic nano-biomolecular condensates controlling the dynamic clustering of recycling synaptic vesicles

Early hippocampal hyperexcitability and synaptic reorganization in mouse models of amyloidosis

Impairments in Endogenous AMPA Receptor Dynamics Correlates with Learning Deficits in Alzheimer's Disease Model Mice.

Altered patterning of neural activity in a tauopathy mouse model

Tau pathology does not affect experience-driven single-neuron and network-wide Arc/Arg3.1 responses

Mechanistic insights into NAD synthase NMNAT chaperoning phosphorylated Tau from pathological aggregation

Cryo-electron tomography reveals postsynaptic nanoblocks in excitatory synapses